Related Experiment Videos
HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy
AIDS (London, England)
|July 15, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Viral co-infection, autoimmunity, and CSF HIV antibody profiles in HIV central nervous system escape.
Journal of neuroimmunology·2023
Severe multisystem inflammatory syndrome (MIS-C/A) after confirmed SARS-CoV-2 infection: a report of four adult cases.
Infectious diseases (London, England)·2022
Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration.
British journal of clinical pharmacology·2018
Cost-effectiveness of a systematic e-assessed follow-up of postoperative recovery after day surgery: a multicentre randomized trial.
British journal of anaesthesia·2017
Real-life durability and virological outcomes of doravirine in people with multidrug-resistant HIV.
AIDS (London, England)·2026
Cancer incidence and risk factors among people with HIV in REPRIEVE.
AIDS (London, England)·2026
Effects of semaglutide on subclinical cardiovascular health in people with HIV.
AIDS (London, England)·2026
Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.
AIDS (London, England)·2026
Methotrexate Modulates Polymorphonuclear Neutrophil Function Through Reduced Chemotaxis and Increased LOX-1 Expression.
Immunity, inflammation and disease·2026
Non-invasive functional neurosurgery revisited: The emerging role of MRgFUS in neuropsychiatric disorders.
Dental and medical problems·2026
Switching to Pegmolesatide in Maintenance Dialysis: Real-World Hemoglobin Response, Temporal Dynamics, and Modality-Specific Predictors.
Drug design, development and therapy·2026
Tetrahedral Framework Nucleic Acid-Based Small RNA Delivery: Prospects and Challenges in Bone and Cartilage Regeneration.
Advanced healthcare materials·2026
Mesenchymal Stromal Cells Fuel Immunometabolic Reprogramming of Type 2 Conventional Dendritic Cells to Alleviate Systemic Sclerosis.
Arthritis & rheumatology (Hoboken, N.J.)·2026